State Street
TERN

State Street’s Terns Pharmaceuticals TERN Stock Holding History

State Street’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113M Buy
2,139,662
+363,740
+20% +$14.9M ﹤0.01% 1311
2025
Q4 		$71.7M Buy
1,775,922
+170,229
+11% +$3.93M ﹤0.01% 1538
2025
Q3 		$12.1M Buy
1,605,693
+232,252
+17% +$1.48M ﹤0.01% 2534
2025
Q2 		$5.12M Buy
1,373,441
+48,924
+4% +$153K ﹤0.01% 2930
2025
Q1 		$3.66M Buy
1,324,517
+37,474
+3% +$153K ﹤0.01% 3003
2024
Q4 		$7.13M Buy
1,287,043
+170,052
+15% +$1.15M ﹤0.01% 2803
2024
Q3 		$9.32M Sell
1,116,991
-59,842
-5% -$492K ﹤0.01% 2647
2024
Q2 		$8.01M Buy
1,176,833
+271,339
+30% +$1.64M ﹤0.01% 2694
2024
Q1 		$5.94M Buy
905,494
+18,615
+2% +$122K ﹤0.01% 2858
2023
Q4 		$5.76M Buy
886,879
+8,680
+1% +$45.9K ﹤0.01% 2883
2023
Q3 		$4.42M Buy
878,199
+57,477
+7% +$365K ﹤0.01% 2978
2023
Q2 		$7.18M Buy
820,722
+701,683
+589% +$8.18M ﹤0.01% 2813
2023
Q1 		$1.41M Buy
119,039
+59,502
+100% +$569K ﹤0.01% 3433
2022
Q4 		$606K Buy
59,537
+17,500
+42% +$116K ﹤0.01% 3702
2022
Q3 		$248K Buy
42,037
+22,200
+112% +$82.5K ﹤0.01% 4043
2022
Q2 		$49K Sell
19,837
-143,400
-88% -$286K ﹤0.01% 4727
2022
Q1 		$485K Buy
163,237
+1,218
+0.8% +$5.2K ﹤0.01% 4061
2021
Q4 		$1.15M Buy
162,019
+11,679
+8% +$97.3K ﹤0.01% 3783
2021
Q3 		$1.57M Buy
150,340
+21,637
+17% +$224K ﹤0.01% 3676
2021
Q2 		$1.58M Buy
128,703
+30,056
+30% +$512K ﹤0.01% 3584
2021
Q1 		$2.17M Buy
+98,647
New +$2.16M ﹤0.01% 3408

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

State Street's TERN Position: Q1 2026 in Review

State Street increased its Terns Pharmaceuticals (TERN) stake by 20% in Q1 2026, buying an estimated $14.9M and bringing the position to 2,139,662 shares worth $113M. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

State Street first reported a position in TERN in Q1 2021 and has held it in 21 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • State Street held 2,139,662 shares of Terns Pharmaceuticals worth $113M as of Q1 2026.
  • State Street bought 363,740 Terns Pharmaceuticals shares in Q1 2026, an estimated $14.9M.
  • Terns Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1311 holding.
  • State Street first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.